Year :
2025
| Month :
November
| Volume :
19
| Issue :
11
| Page :
OD05 - OD07
Full Version
A Case Report on Post-haemodialysis Pyrexia Caused due to a Rare Species of Trichosporon
Published: November 1, 2025 | DOI: https://doi.org/10.7860/JCDR/2025/81615.21976
Aman Kumar Gupta, Sourya Acharya, Sunil Kumar, Dipika Shaw, Anjali Patond
1. Junior Resident, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
2. Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
3. Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
4. Assistant Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
5. Assistant Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
Correspondence Address :
Dr. Aman Kumar Gupta,
Junior Resident, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha-442001, Maharashtra, India.
E-mail: amangupta1907@gmail.com
Abstract
Hypertension is a global health threat, which, in coexistence with chronic kidney disease, increases the associated health risks. Most of the vulnerable patients receive prophylactic therapeutic intervention for fungal infections, though, in a few instances, there is a delay in symptomatic presentation. The patients with hypertension and chronic kidney disease receiving haemodialysis should be monitored strictly for the same. This is a case of a 41-year-old male infected with Trichosporon infection with a positive history of hypertension and chronic kidney disease, receiving haemodialysis treatment. The patient was timely confirmed to have the diagnosis and successfully managed with the systemic antifungal drug Itraconazole {100 mg (BD) for 14 days} and Fluoroquinolones {500 mg (OD) for seven days}. A follow-up at one month showed the patient with laboratory markers within normal limits.
Keywords
Chronic kidney disease, Immunosuppressed, Microbial infections, Post-transplant infections, Trichosporonosis, Trichosporon species
DOI: 10.7860/JCDR/2025/81615.21976
Date of Submission: Jun 27, 2025
Date of Peer Review: Jul 15, 2025
Date of Acceptance: Sep 10, 2025
Date of Publishing: Nov 01, 2025
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 06, 2025
• Manual Googling: Sep 06, 2025
• iThenticate Software: Sep 08, 2025 (7%)
ETYMOLOGY: Author Origin
EMENDATIONS: 6
|